In one study, obese mice treated with an mRNA for FGF21 showed reversal of obesity-related metabolic derangements, indicating that mRNA delivery of endocrine factors is feasible and can have potent effects [105]. This evidence concerns the gene FGF21 and obesity due to melanocortin 4 receptor deficiency.